Statement on sarcoidosis

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 736-755

  Hunninghake, Gary W ^a   Costabel, Ulrich ^a   Ando, Masayuki ^a   Baughman, Robert ^a   Cordier, Jean François ^a   Du Bois, Ronald ^a   Eklund, Anders ^a   Kitaichi, Masanori ^a   Lynch, Joseph ^a   Rizzato, Gianfranco ^a   Rose, Cecil ^a   Selroos, Olof ^a   Semenzato, Gianpietro ^a   Sharma, Om P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; CORTICOSTEROID; CYTOTOXIN;

HEREDITY; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; GRANULOMA; LUNG; LUNG DISEASE; PATHOLOGY; PROGNOSIS;

ADRENAL CORTEX HORMONES; CYTOTOXINS; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; GRANULOMA; HUMANS; LUNG; LUNG DISEASES; PROGNOSIS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 0033172779     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.ats4-99     Document Type: Review

References (331)

1. 1. Yamamoto, M., O. P. Sharma, and Y. Hosoda. 1992. Special report: the 1991 descriptive definition of sarcoidosis. Sardoidosis 9:33-34.
2. 2. James, D. G. 1997. Descriptive definition and historic aspects of sarcoidosis. Clin. Chest Med. 18:663-679.
3. 3. Hosoda, Y., and M. Odaka. 1992. History of sarcoidosis. Semin. Respir. Med. 13:359-367.
4. 4. Hutchinson, J. 1877. Case of livid papillary psoriasis. In Illustrations of Clinical Surgery, Vol. 1. J&A Churchill, London. 42-43.
5. 5. Hutchinson, J. 1898. On eruptions which occur in connection with gout: case of Mortimer's malady. Arch. Surg. 9:307-314.
6. 6. Boeck, C. 1899. Multiple benign hud-sarkoid. Norsck Laegevidensk 60: 1321.
7. 7. Boeck, C. 1899. Multiple benign sarkoid of the skin. J. Cutan. Genitourinary Dis. 17:543-550.
8. 8. Besnier, M. 1899. Lupus pernio de la face: synovites funguesues (scrofulo-tuberculeuses) symetriques des extremities superieures. Ann. Dermatol. Syphiligr. 10:33-36.
9. 9. Tenneson, M. 1892. Lupus pernio (Lupus pernio). Bull. Soc. Fr. Dermatol. Syphiligr. 3:417-419.
10. 10. Kreibich, K. 1904. Ueber lupus pernio. Arch. Derm. Syph. (Wien) 71:13-16.
11. 11. Jüngling, O. 1920. Ostitis tuberculosa multiplex cystica. Fortschr. Geb. Roentgenstr. 27:375-383.
12. 12. Heerfordt, C. 1909. Uber eine Febris uveo-parotidea subchronica. Von Graefe's Arch. Opthalmol. 70:254-273.
13. 13. Kuznitsky, E., and A. Bittorf. 1915. Sarkoid mit Beteiligung innerer Organe. Münch. Med. Wochenschr. 1349-1353.
14. 14. Schaumann, J. 1916-1917. Etude Sur le lupus pernio et ses rapports avec les sarcoides et la tuberculose. Ann. Dermatol. Syphiligr. 357-363.
15. 15. Schaumann, J. 1934. Etude anatomo pathologique et histologique sur les localisations viscerales de la lymphogranulomatose benigne. Bull. Soc. Fr. Dermatol. Syphiligr. 1167-1322.
16. 16. Harrell, G., and S. Fisher. 1939. Blood chemical changes in Boeck's sarcoid with particular reference to protein, calcium, and phosphatase values. J. Clin. Invest. 18:687-693.
17. 17. Kveim, A. 1941. En ny og spesifikk kutan-reaksjon ved Boecks sarcoid. Nord. Med. 9:169-172.
18. 18. Williams, R., and D. Nickerson. 1935. Skin reactions in sarcoid. Proc. Soc. Exp. Biol. Med. 33:403-405.
19. 19. Siltzbach, L. 1961. The Kveim test in sarcoidosis: a study of 750 patients. J.A.M.A. 178:476-482.
20. 20. Löfgren, S. 1946. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med. Scand. 124:1-197.
21. 21. Longscope, W., and D. Frieman. 1952. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 31:1-142.
22. 22. Maycock, R. I., P. Bertrand, C. E. Morrison, and J. H. Scott. 1963. Manifestations of sarcoidosis: analysis of 145 patients with review of nine series selected from the literature. Am. J. Med. 35:67-89.
23. 23. Scadding, J. 1961. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after 5 years' observations. Br. Med. J. 2:1165-1172.
24. 24. Siltzback, L. 1967. Sarcoidosis: clinical features and management. Med. Clin. North Am. 51:483-502.
25. 25. Siltzbach, L. E., D. G. James, E. Neville, J. Turiaf, J. P. Battesti, O. P. Sharma, Y. Hosoda, R. Mikami, and M. Odaka. 1974. Course and prognosis of sarcoidosis around the world. Am. J. Med. 57:847-852.
26. 26. James, D. G., E. Neville, and L. E. Siltzbach. 1976. A worldwide review of sarcoidosis. Ann. N.Y. Acad. Sci. 278:321-334.
27. 27. Israel, H., and M. Sones. 1958. Sarcoidosis: clinical observation on 161 cases. Ann. Intern. Med. 102:766-775.
28. 28. Neville, E., A. N. Walker, and D. G. James. 1983. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q. J. Med. 52:525-533.
29. 29. Romer, F. K. 1982. Presentation of sarcoidosis and outcome of pulmonary changes. Dan. Bull. Med. 29:27-32.
30. 30. Hillerdal, G., E. Nou, K. Osterman, and B. Schmekel. 1984. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am. Rev. Respir. Dis. 130:29-32.
31. 31. Sones, M., H. L. Israel, M. B. Dratman, and J. H. Frank. 1951. Effect of cortisone in sarcoidosis. N. Engl. J. Med. 244:209-213.
32. 32. Siltzbach, L. E. 1952. Effects of cortisone in sarcoidosis: a study of 13 patients. Am. J. Med 12:139-160.
33. 33. Smellie, H., G. H. Apthorp, and R. Marshal. 1961. The effect of corticosteroid treatment on pulmonary function in sarcoidosis. Thorax 16: 87-90.
34. 34. Sharma, O. P., C. Colp, and M. H. Williams, Jr. 1966. Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies. Am. J. Med. 41:541-551.
35. 35. Johns, C. J., J. B. Zachary, and W. C. Ball, Jr. 1974. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med. J. 134:271-283.
36. 36. Johns, C. J., S. A. Schonfeld, P. P. Scott, J. B. Zachary, and M. I. MacGregor. 1986. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy: outcome and complications. Ann. N.Y. Acad. Sci. 465:702-712.
37. 37. Emergil, C., B. J. Sobol, and M. H. Williams. 1969. Long-term study of pulmonary sarcoidosis: the effects of steroid therapy as evaluated by pulmonary function studies. J. Chronic Dis. 22:69-86.
38. 38. Wurm, K., H. Reindell, and L. Heilmeyer. 1958. Der Lungenboeck in Röntgenbild. Thieme, Stuttgart, Germany.
39. 39. Eule, H., A. Weinecke, I. Roth, and H. Wuthe. 1986. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis: late results of a continuing clinical study. Ann. N.Y. Acad. Sci. 465:695-701.
40. 40. Israel, H. L., D. W. Fouts, and R. A. Beggs. 1973. A controlled trial of prednisone treatment of sarcoidosis. Am. Rev. Respir. Dis. 107:609-614.
41. 41. Selroos, O., and T. L. Sellergren. 1979. Corticosteroid therapy of pulmonary sarcoidosis: a prospective evaluation of alternate day and daily dosage in stage II disease. Scand. J. Respir. Dis. 60:215-221.
42. 42. Yamamoto, M., N. Saito, and T. Tachibana. 1980. Effects of an 18 month corticosteroid therapy to stage I and stage II sarcoidosis patients (control trial). In J. Chreiten, J. Marsac, and J. Saltiel, editors. Sarcoidosis and Other Granulomatous Disorders. Pergamon Press, Paris. 470-474.
43. 43. Young, R. L., L. E. Harkleroad, R. E. Lordon, and J. G. Weg. 1970. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann. Intern. Med. 73:207-212.
44. 44. Zaki, M. H., H. A. Lyons, L. Leilop, and C. T. Huang. 1987. Corticosteroid therapy in sarcoidosis: a five-year, controlled follow-up study. N. Y. State J. Med. 87:496-499.
45. 45. Gibson, G. J., R. J. Prescott, M. F. Muers, W. G. Middleton, D. N. Mitchell, C. K. Connolly, and B. D. Harrison. 1996. British Thoracic Society Sarcoidosis Study: effects of long term corticosteroid treatment [see comments]. Thorax 51:238-247.
46. 46. James, D. G., L. S. Carstairs, J. Trowell, and O. P. Sharma. 1967. Treatment of sarcoidosis: report of a controlled therapeutic trial. Lancet 2:526-528.
47. 47. Koerner, S. K., A. J. Sakowitz, R. I. Appelman, N. H. Becker, and S. W. Schoenbaum. 1975. Transbronchial lung biopsy for the diagnosis of sarcoidosis. N. Engl. J. Med. 293:268-270.
48. 48. Koontz, C. H., R. J. Lee, and R. A. Nelson. 1976. Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann. Intern, Med. 85:64-66.
49. 49. Roethe, R. A., P. B. Fuller, R. B. Byrd, and D. R. Hafermann. 1980. Transbronchoscopic lung biopsy in sarcoidosis: optimal number and sites for diagnosis. Chest 77:400-402.
50. 50. Hunninghake, G. W., and R. G. Crystal. 1981. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N. Engl. J. Med. 305:429-434.
51. 51. Thomas, P. D., and G. W. Hunninghake. 1987. Current concepts of the pathogenesis of sarcoidosis. Am. Rev. Respir, Dis. 135:747-760.
52. 52. James, D. G., E. Neville, and A. Walker. 1975. Immunology of sarcoidosis. Am. J. Med. 59:388-394.
53. 53. Lieberman, J. 1975. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am. J. Med. 59:365-372.
54. 54. Crystal, R. G., R. C. Roberts, G. W. Hunninghake, J. E. Gadek, J. D. Fulmer, and B. R. Line. 1981. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann. Intern. Med. 94:73-94.
55. 55. Daniele, R. P., J. H. Dauber, and M. D. Rossman. 1980. Immunologic abnormalities in sarcoidosis. Ann. Intern. Med. 92:406-416.
56. 56. Line, B. R., G. W. Hunninghake, B. A. Keogh, A. E. Jones, G. S. Johnston, and R. G. Crystal. 1981. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am. Rev. Respir. Dis. 123: 440-446.
57. 57. Hennessy, T. W., D. J. Ballard, R. A. DeRemee, C. P. Chu, and L. J. D. Melton. 1988. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935-1984. J. Clin. Epidemiol. 41:565-570.
58. 58. Gordis, L. 1973. Sarcoidosis: Epidemiology of Chronic Lung Diseases in Children. The John Hopkins University Press, Baltimore. 53-78.
59. 59. Alsbirk, P. H. 1964. Epidemiologic studies on sarcoidosis in Denmark based on a nationwide central register: a preliminary report. Acta Med. Scand. 176:106-109.
60. 60. Iwai, K., M. Sekiguti, Y. Hosoda, R. A. DeRemee, H. D. Tazelaar, O. P. Sharma, A. Maheshwari, and T. I. Noguchi. 1994. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26-31.
61. 61. Milman, N., and O. Selroos. 1990. Pulmonary sarcoidosis in the Nordic countries 1950-1982: epidemiology and clinical picture. Sarcoidosis. 7:50-57.
62. 62. Henke, C. E., G. Henke, L. R. Elveback, C. M. Beard, D. J. Ballard, and L. T. Kurland. 1986. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am. J. Epidemiol. 123:840-845.
63. 63. Rybicki, B. A., M. Major, J. Popovich, Jr., M. J. Maliarik, and M. C. Iannuzzi. 1997. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am. J. Epidemiol. 145:234-241.
64. 64. Bresnitz, E. A., and B. L. Strom. 1983. Epidemiology of sarcoidosis. Epidemiol. Rev. 5:124-156.
65. 65. James, G. D. 1994. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York.
66. 66. Mana, J., F. Badrinas, J. Morera, E. Fite, F. Manresa, and F. Fernandez-Nogues. 1992. Sarcoidosis in Spain. Sarcoidosis 9:118-122.
67. 67. Keller, A. Z. 1971. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am. J. Epidemiol. 94:222-230.
68. 68. Mitchell, D. N., and J. G. Scadding. 1974. Sarcoidosis. Am. Rev. Respir. Dis. 110:774-802.
69. 69. McNicol, M. W., and P. J. Luce. 1985. Sarcoidosis in a racially mixed community. J. R. Coll. Physicians Lond. 19:179-183.
70. 70. Edmondstone, W. M., and A. G. Wilson. 1985. Sarcoidosis in Caucasians, Blacks and Asians in London. Br. J. Dis. Chest 79:27-36.
71. 71. Pietinalho, A., M. Ohmichi, Y. Hiraga, A. B. Lofroos, and O. Selroos. 1996. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc. Diffuse Lung Dis. 13:159-166.
72. 72. Iwai, K., T. Tachibana, T. Takemura, Y. Matsui, M. Kitaichi, and Y. Kawabata. 1993. Pathological studies on sarcoidosis autopsy: I. Epidemiological features of 320 cases in Japan. Acta Pathol. Jpn. 43: 372-376.
73. 73. Iwai, K., T. Takemura, M. Kitaichi, Y. Kawabata, and Y. Matsui. 1993. Pathological studies on sarcoidosis autopsy: II. Early change, mode of progression and death pattern. Acta Pathol. Jpn. 43:377-385.
74. 74. Gideon, N. M., and D. M. Mannino. 1996. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am. J. Med. 100:423-427.
75. 75. Parkes, S. A., S. B. Baker, R. E. Bourdillon, C. R. Murray, and M. Rakshit. 1987. Epidemiology of sarcoidosis in the Isle of Man: 1. A case controlled study. Thorax 42:420-426.
76. 76. Hills, S. E., S. A. Parkes, and S. R. Baker. 1987. Epidemiology of sarcoidosis in the Isle of Man: 2. Evidence for space-time clustering. Thorax 42:427-430.
77. 77. Bardinas, F., J. Morera, E. Fite, and A. Plasencia. 1989. Seasonal clustering of sarcoidosis [Letter]. Lancet 2:455-456.
78. 78. Glennas, A., T. K. Kvien, K. Melby, O. K. Refvem, O. Andrup, B. Karstensen, and J. E. Thoen. 1995. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br. J. Rheumatol. 34:45-50.
79. 79. Gentry, J. T., H. M. Nitowsky, and M. Michael. 1955. Studies on the epidemiology of sarcoidosis in the United States: the relationship to soil areas and to urban-rural residence. J. Clin. Invest. 34:1839-1856.
80. 80. Cummings, M. M., E. Dunner, and J. H. William. 1959. Epidemiologic and clinical observations in sarcoidosis. Ann. Intern. Med. 50:879-890.
81. 81. Comstock, G. W., H. Keltz, and D. J. Spencer. 1961. Clay eating and sarcoidosis: a controlled study in the state of Georgia. Am. Rev. Respir. Dis. 84:S130-S134.
82. 82. Buck, A. A. 1961. Epidemiologic investigations of sarcoidosis: I. Introduction - material and methods. Am. J. Hyg. 74:137-151.
83. 83. Buck, A. A., and P. E. Sartwell. 1961. Epidemiologic investigations of sarcoidosis: II. Skin sensitivity and environmental factors. Am. J. Hyg. 74:152-173.
84. 84. Buck, A. A., and V. A. McKusick. 1961. Epidemiologic investigations of sarcoidosis: III. Serum proteins; syphilis; association with tuberculosis; familial aggregation. Am. J. Hyg. 74:174-188.
85. 85. Buck, A. A. 1961. Epidemiologic investigations of sarcoidosis: IV. Discussion and summary. Am. J. Hyg. 74:189-202.
86. 86. Horwitz, O. 1961. Geographic epidemiology of sarcoidosis in Denmark. Am. Rev. Respir. Dis. 84:S135-S142.
87. 87. Douglas, A. C. 1961. Sarcoidosis in Scotland. Am. Rev. Respir. Dis. 84: S143-SI47.
88. 88. Redline, S., B. P. Barna, J. F. Tomashefski, Jr., and J. L. Abraham. 1986. Granulomatous disease associated with pulmonary deposition of titanium. Br. J. Indian. Med. 43:652-656.
89. 89. De Vuyst, P., P. Dumortier, L. Schandene, M. Estenne, A. Verhest, and J. C. Yernault. 1987. Sarcoidlike lung granulomatosis induced by aluminum dusts. Am. Rev. Respir. Dis. 135:493-497.
90. 90. Skelton, H. G. D., K. J. Smith, F. B. Johnson, C. R. Cooper, W. F. Tyler, and G. P. Lupton. 1993. Zirconium granuloma resulting from an aluminum zirconium complex: a previously unrecognized agent in the development of hypersensitivity granulomas. J. Am. Acad. Dermatol. 28:874-876.
91. 91. Parkes, S. A., S. B. Baker, R. E. Bourdillon, C. R. Murray, M. Rakshit, J. W. Sarkies, J. P. Travers, and F. W. Williams. 1985. Incidence of sarcoidosis in the Isle of Man. Thorax 40:284-287.
92. 92. Bresnitz, E. A., P. D. Stolley, H. L. Israel, and K. Soper. 1986. Possible risk factors for sarcoidosis: a case-control study. Ann. N.Y. Acad. Sci. 465:632-642.
93. 93. Edmondstone, W. M. 1988. Sarcoidosis in nurses: is there an association? Thorax 43:342-343.
94. 94. Kern, D. G., M. A. Neill, D. S. Wrenn, and J. C. Varone. 1993. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am. Rev. Respir. Dis. 148:974-980.
95. 95. 1997. Sarcoidosis among U.S. Navy enlisted men, 1965-1993. M.M.W.R. 46:539-543.
96. 96. Douglas, J. G., W. G. Middleton, J. Gaddie, G. R. Petrie, Y. F. Choo-Kang, R. J. Prescott, and G. K. Crompton. 1986. Sarcoidosis: a disorder commoner in non-smokers? Thorax 41:787-791.
97. 97. Revsbech, P. 1992. Is sarcoidosis related to exposure to pets or the housing conditions? A case-referent study. Sarcoidosis 9:101-103.
98. 98. Valeyre, D., P. Soler, C. Clerici, J. Pre, J. P. Battesti, R. Georges, and A. J. Hance. 1988. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 43:516-524.
99. 99. Harrington, D. W., M. Major, B. Rybicki, J. Popovich, M. Maliarik, and M. C. Iannuzzi. 1994. Familial sarcoidosis: analysis of 91 families. Sarcoidosis 11:240-243.
100. 100. Brennan, N. J., P. Crean, J. P. Long, and M. X. Fitzgerald. 1984. High prevalence of familial sarcoidosis in an Irish population. Thorax 39: 14-18.
101. 101. Hiraga, Y., Y. Hosoda, and I. Zenda. 1977. A local outbreak of sarcoidosis in northern Japan. Z. Erkr. Atmungsorgane 149:38-43.
102. 102. Pasturenzi, L., M. Martinetti, M. Cuccia, A. Cipriani, G. Semenzato, and M. Luisetti. 1993. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis: The Pavia-Padova Sarcoidosis Study Group. Chest 104:1170-1175.
103. 103. Gardner, J., H. G. Kennedy, A. Hamblin, and E. Jones. 1984. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 39:19-22.
104. 104. Lenhart, K., V. Kolek, and A. Bartova. 1990. HLA antigens associated with sarcoidosis. Dis. Markers 8:23-29.
105. 105. Heyll, A., G. Meckenstock, C. Aul, D. Sohngen, F. Borchard, U. Hadding, U. Modder, M. Leschke, and W. Schneider. 1994. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant. 14:161-164.
106. 106. Semenzato, G., A. Pezzutto, M. Chilosi, and G. Pizzolo. 1982. Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis [Letter]. N. Engl. J. Med. 306:48-49.
107. 107. Konishi, K., D. R. Moller, C. Saltini, M. Kirby, and R. G. Crystal. 1988. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J. Clin. Invest. 82:775-781.
108. 108. Robinson, R. B. W., T. L. McLemore, and R. G. Crystal. 1988. Gamma interferon is spontaneously released by alveolary macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1488-1505.
109. 109. Baughman, R. P., S. A. Strohofer, J. Buchsbaum, and E. E. Lower. 1990. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J. Lab. Clin. Med. 115:36-42.
110. 110. Moller, D. R., J. D. Forman, M. C. Liu, P. W. Noble, B. M. Greenlee, P. Vyas, D. A. Holden, J. M. Forrester, A. Lazarus, M. Wysocka, G. Trinchieri, and C. Karp. 1996. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156:4952-4960.
111. 111. Agostini, C., L. Trentin, M. Facco, R. Sancetta, A. Cerutti, C. Tassinari, L. Cimarosto, F. Adami, A. Cipriani, R. Zambello, and G. Semenzato. 1996. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157: 910-918.
112. 112. Moller, D. R., K. Konishi, M. Kirby, B. Balbi, and R. G. Crystal. 1988. Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J. Clin. Invent. 82: 1183-1191.
113. 113. Grunewald, J., O. Olerup, U. Persson, M. B. Ohrn, H. Wigzell, and A. Eklund. 1994. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl. Acad. Sci. U.S.A. 91:4965-4969.
114. 114. Forman, J. D., J. T. Klein, R. F. Silver, M. C. Liu, B. M. Greenlee, and D. R. Moller. 1994. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J. Clin. Invest. 94:1533-1542.
115. 115. Trentin, L., R. Zambello, M. Facco, C. Tassinari, R. Sancetta, M. Siviero, A. Cerutti, A. Cipriani, G. Marcer, M. Majori, A. Pesci, C. Agostini, and G. Semenzato. 1997. Selection of T lymphocytes bearing limited TCR-Vbeta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. Am. J. Respir. Crit. Care Med. 155:587-596.
116. 116. Grunewald, J., T. Hultman, A. Bucht, A. Eklund, and H. Wigzell. 1995. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med. 1:287-296.
117. 117. DuBois, R. M., M. Kirby, B. Balbi, C. Saltini, and R. G. Crystal. 1983. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of T-cell antigen receptor. Am. Rev. Respir. Dis. 145:1205-1211.
118. 118. Semenzato, G. 1997. Bias toward use of T-cell receptor variable regions in the lung: research tool or clinically useful technique? Eur. Respir. J. 10:767-769.
119. 119. Perez, R. L., J. Roman, G. W. Staton, Jr., and R. L. Hunter. 1994. Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. Am. J. Respir. Crit. Care Med. 149:510-518.
120. 120. Martinetti, M., C. Tinelli, V. Kolek, M. Cuccia, L. Salvaneschi, L. Pasturenzi, G. Semenzato, A. Cipriani, A. Bartova, and M. Luisetti. 1995. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am. J. Respir. Crit. Care Med. 152:557-564.
121. 121. Berlin, M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156:1601-1605.
122. 122. Kunikane, H., S. Abe, E. Yamaguchi, J. M. Aparicio, A. Wakisaka, T. Yoshiki, and Y. Kawakami. 1994. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis. Thorax 49:573-576.
123. 123. Abe, S., E. Yamaguchi, S. Makimura, N. Okazaki, H. Kunikane, and Y. Kawakami. 1987. Association of HLA-DR with sarcoidosis: correlation with clinical course. Chest 92:488-490.
124. 124. Mitchell, D. N., and R. J. Rees. 1969. A transmissible agent from sarcoid tissue. Lancet 2:81-84.
125. 125. Newman, L. S. 1995. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 12:7-19.
126. 126. Mangiapan, G., and A. J. Hance. 1995. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 12:20-37.
127. 127. Milman, N., and A. B. Andersen. 1993. Detection of antibodies in serum against M. tuberculosis using Western blot technique: comparison between sarcoidosis patients and healthy subjects. Sarcoidosis 10:29-31.
128. 128. Chapman, J. S., and M. Speight. 1964. Further studies of mycobacterial antibodies in the sera of sarcoidosis patients. Acta Med. Scand. Suppl. 425:61-67.
129. 129. Hanngren, A., G. Odham, A. Eklund, S. Hoffner, N. Stjernberg, and G. Westerdahl. 1987. Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 4:101-104.
130. 130. Eishi, Y., N. Ando, T. Takemura, and Y. Matui. 1992. Pathogenesis of granuloma formation in lymph nodes with sarcoidosis. Sarcoidosis 9:669.
131. 131. Almenoff, P. L., A. Johnson, M. Lesser, and L. H. Mattman. 1996. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 51:530-533.
132. 132. Saboor, S. A., N. M. Johnson, and J. McFadden. 1992. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 339:1012-1015.
133. 133. Mitchell, I. C., J. L. Turk, and D. N. Mitchell. 1992. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation [see comments]. Lancet 339:1015-1017.
134. 134. Agostini, C., L. Trentin, R. Zambello, P. Bulian, F. Siviero, M. Masciarelli, G. Festi, A. Cipriani, and G. Semenzato. 1993. CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. Am. J. Med. 95:466-472.
135. 135. Kreipe, H., H. J. Radzun, K. Heidorn, J. Barth, J. Kiemle-Kallee, W. Petermann, J. Gerdes, and M. R. Parwaresch. 1990. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. Lab. Invest. 62:697-703.
136. 136. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:235-244.
137. 137. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract [first of two parts]. N. Engl. J. Med. 310:154-166.
138. 138. Semenzato, G., and C. Agostini. 1998. Immunologic events in the development of interstitial lung disease: the paradigm of sarcoidosis. In M. I. Schwarz and T. E. King, Jr., editors. Interstitial Lung Disease, 3rd ed. Marcel Dekker, Hamilton, ON, Canada. 229-250.
139. 139. Agostini, C. R. Zambello, R. Sancetta, A. Cerutti, A. Milani, C. Tassinari, M. Facco, A. Cipriani, L. Trentin, and G. Semenzato. 1996. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am. J. Respir. Crit. Care Med. 153:1359-1367.
140. 140. Devergne, O., A. Marfaing-Koka, T. J. Schall, M. B. Leger-Ravet, M. Sadick, M. Peuchmaur, M. C. Crevon, K. J. Kim, T. T. Schall, T. Kim, et al. 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J. Exp. Med. 179:1689-1694. [Published erratum appears in J. Exp. Med. 1994;180(2): 775.]
141. 141. Taub, D. D., M. Anver, J. J. Oppenheim, D. L. Longo, and W. J. Murphy. 1996. T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J. Clin. Invest. 97:1931-1941.
142. 142. Saltini, C., J. R. Spurzem, J. J. Lee, P. Pinkston, and R. G. Crystal. 1986. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+T cell subset. J. Clin. Invest. 77:1962-1970.
143. 143. Semenzato, G., C. Agostini, L. Trentin, R. Zambello, M. Chilosi, A. Cipriani, F. Ossi, M. R. Angi, L. Morittu, and G. Pizzolo. 1984. Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin. Exp. Immunol. 57:331-337.
144. 144. Pinkston, P., P. B. Bitterman, and R. G. Crystal. 1983. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N. Engl. J. Med. 308:793-800.
145. 145. Hunninghake, G. W., G. N. Bedell, D. C. Zavala, M. Monick, and M. Brady. 1983. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 128:634-638.
146. 146. Kunkel, S. L., N. W. Lukacs, R. M. Strieter, and S. W. Chensue. 1996. Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoidosis Vasc. Diffuse Lung Dis. 13:120-128.
147. 147. Kitaichi, M. 1986. Pathology of pulmonary sarcoidosis. Clin. Dermatol. 4:108-115.
148. 148. Rosen, Y. 1994. Sarcoidosis. In D. H. Dail and S. P. Hammer, editors. Pulmonary Pathology, 2nd ed. Springer-Verlag, New York. 13-645.
149. 149. Sheffield, E. A., and W. J. Williams. 1994. Pathology. In D. G. James, editor. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York. 45-67.
150. 150. Colby, T. V. 1995. Interstitial lung diseases. In W. Thurlbeck and A. Churg, editors. Pathology of the Lung, 2nd ed. Thieme Medical Publishers, New York. 589-737.
151. 151. Churg, A., C. B. Carrington, and R. Gupta. 1979. Necrotizing sarcoid granulomatosis. Chest 76:406-413.
152. 152. Perry, A., and F. Vuitch. 1995. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch. Pathol. Lab. Med. 119:167-172.
153. 153. Lacronique, J., J. Bernaudin, P. Loler, F. Lange, O. Kawanami, G. Saumon, R. Geroges, and F. Basset. 1983. Alveolitis and granulomas: sequential course in pulmonary sarcoidosis. In J. Chretien, J. Marsac, and J. Saltiel, editors. Sarcoidosis and Other Granulomatous Disorders. Pergamon Press, Paris. 36-42.
154. 154. Takemura, T., Y. Matsui, S. Saiki, and R. Mikami. 1992. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum. Pathol. 23:1216-1223.
155. 155. Tuder, R. M. 1996. A pathologist's approach to interstitial lung disease. Curr. Opin. Pulm. Med. 2:357-363.
156. 156. Freiman, D. G., and H. L. Hardy. 1970. Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum. Pathol. 1:25-44.
157. 157. Woodard, B. H., S. I. Rosenberg, R. Farnham, and D. O. Adams. 1982. Incidence and nature of primary granulomatous inflammation in surgically removed material. Am. J. Surg. Pathol. 6:119-129.
158. 158. Miettinen, M. 1981. Histological differential diagnosis between lymph node toxoplasmosis and other benign lymph node hyperplasias. Histopathology 5:205-216.
159. 159. Benjamin, D. R. 1987. Granulomatous lymphadenitis in children. Arch. Pathol. Lab. Med. 111:750-753.
160. 160. Symmans, P. J., K. Brady, and C. E. Keen. 1995. Calcium oxalate crystal deposition in epithelioid histiocytes of granulomatous lymphadenitis: analysis by light and electronmicroscopy. Histopathology 27:423-429.
161. 161. Schnitzer, B. 1995. Reactive lymphoid hyperplasias. In E. Jaffe, editor. Surgical Pathology of Lymph Nodes and Related Organs, 2nd ed. W. B. Saunders, Philadelphia. 98-132.
162. 162. Mehregan, A., K. Hashimoto, D. Mehregan, and D. Mehregan. 1995. Granulomatous inflammation and proliferation. In Pinkus' Guide to Dermatohistopathology, 6th ed. Prentice-Hall International, London. 295-371.
163. 163. Harrington, P. T., J. J. Gutierrez, C. H. Ramirez-Ronda, R. Quinones-Soto, R. H. Bermudez, and J. Chaffey. 1982. Granulomatous hepatitis. Rev. Infect. Dis. 4:638-655.
164. 164. Satti, M. B., H. al-Freihi, E. M. Ibrahim, A. Abu-Melha, G. al-Ghassab, H. Y. al-Idrissi, and M. O. al-Sohaibani. 1990. Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am. J. Gastroenterol. 85:669-674.
165. 165. Bodem, C. R., B. H. Hamory, H. M. Taylor, and L. Kleopfer. 1983. Granulomatous bone marrow disease: a review of the literature and clinicopathologic analysis of 58 cases. Medicine 62:372-383.
166. 166. Neiman, R. S. 1977. Incidence and importance of splenic sarcoid-like granulomas. Arch. Pathol. Lab. Med. 101:518-521.
167. 167. Brincker, H. 1986. Sarcoid reactions in malignant tumors. Cancer Treat. Rev. 13:147-156.
168. 168. Romer, F. 1994. Sarcoidosis and Cancer. In J. James, editor. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York. 401-415.
169. 169. Pickard, W. R., A. H. Clark, and B. J. Abel. 1983. Florid granulomatous reaction in a seminoma. Postgrad. Med. J. 59:334-335.
170. 170. Dietl, J., H. P. Horny, P. Ruck, and E. Kaiserling. 1993. Dysgerminoma of the ovary: an immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells. Cancer 71:2562-2568.
171. 171. Brincker, H. 1994. Granulomatous lesions of unknown significance: the GLUS syndrome. In D. James, editor. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York. 69-86.
172. 172. Brincker, H., and N. T. Pedersen. 1991. Immunohistologic separation of B-cell-positive granulomas from B-cell-negative granulomas in paraffin-embedded tissues with special reference to tumor-related sarcoid reactions. Apmis 99:282-290.
173. 173. Teirstein, A. S., M. L. Padilla, L. R. De Palo, and G. J. Schilero. 1996. Sarcoidosis mythology. Mt. Sinai J. Med. 63:335-341.
174. 174. Nagai, S., and T. Izumi. 1995. Pulmonary sarcoidosis: population differences and pathophysiology. South. Med. J. 88:1001-1010.
175. 175. Lynch, J. P., III, O. P. Sharma, and R. P. Baughman. 1998. Extrapulmonary sarcoidosis [In Process Citation]. Semin. Respir. Infect. 13:229-254.
176. 176. Telenti, A., and P. E. Hermans. 1989. Idiopathic granulomatosis manifesting as fever of unknown origin. Mayo Clin. Proc. 64:44-50.
177. 177. Hendrick, D. J., R. A. Blackwood, and J. M. Black. 1976. Chest pain in the presentation of sarcoidosis. Br. J. Dis. Chest 70:206-210.
178. 178. Bechtel, J. J., T. D. Starr, D. R. Dantzker, and J. S. Bower. 1981. Airway hyperreactivity in patients with sarcoidosis. Am. Rev. Respir. Dis. 124:759-761.
179. 179. Lynch, J. P., III, E. A. Kazerooni, and S. E. Gay. 1997. Pulmonary sarcoidosis. Clin. Chest Med. 18:755-785.
180. 180. Salazar, A., J. Mana, X. Corbella, J. M. Albareda, and R. Pujol. 1995. Splenomegaly in sarcoidosis: a report of 16 cases. Sarcoidosis 12:131-134.
181. 181. Fahy, G. J., T. Warwick, C. J. McCreery, P. J. Quigley, and B. J. Maurer. 1996. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109:62-66.
182. 182. Kinney, E. L., and J. W. Caldwell. 1990. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 41:573-576.
183. 183. Maddrey, W. C., C. J. Johns. J. K. Boitnott, and F. L. Iber. 1970. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine 49:375-395.
184. 184. Siltzbach, L. E. 1965. Sarcoidosis. In J. J. Rovinsky and A. F. C. Guttmacker, editors. Medical, Surgical and Gynecologic Complications of Pregnancy. William & Wilkins, Baltimore. 150.
185. 185. Devancy, K., Z. D. Goodman, M. S. Epstein, H. J. Zimmerman, and K. G. Ishak. 1993. Hepatic sarcoidosis: clinicopathologic features in 100 patients. Am. J. Surg. Pathol. 17:1272-1280.
186. 186. Lower, E. E., J. T. Smith, O. J. Martelo, and R. P. Baughman. 1988. The anemia of sarcoidosis. Sarcoidosis 5:51-55.
187. 187. Valla, D., H. Pessegueiro-Miranda, C. Degott, D. Lebrec, B. Rueff, and J. P. Benhamou. 1987. Hepatic sarcoidosis with portal hypertension: a report of seven cases with a review of the literature. Q. J. Med. 63: 531-544.
188. 188. Vatti, R., and O. P. Sharma. 1997. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc. Diffuse Lung Dis. 14:73-76.
189. 189. Sharma, O. P. 1972. Cutaneous sarcoidosis: clinical features and management. Chest 61:320-325.
190. 190. James, D. 1992. Sarcoidosis of the skin. Semin. Respir. Med. 13:422-441.
191. 191. Karma, A. 1979. Ophthalmic changes in sarcoidosis. Acta Ophthalmol. Suppl. 141:1-94.
192. 192. Oksanen, V. E. 1994. Neurosarcoidosis. In D. G. James, editor. Sarcoidosis and Other Granulomatous Disorders, Vol. 73. Marcel Dekker, New York. 285-309.
193. 193. Chapelon, C., J. M. Ziza, J. C. Piette, Y. Levy, G. Raguin, B. Wechsler, M. O. Bitker, O. Bletry, D. Laplane, M. G. Bousser, et al. 1990. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 69:261-276.
194. 194. Sharma, O. P. 1997. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112:220-228.
195. 195. Williams, D. W. D., A. D. Elster, and S. I. Kramer. 1990. Neurosarcoidosis: gadolinium-enhanced MR imaging. J. Comput. Assist. Tomogr. 14:704-707.
196. 196. Gran, J. T., and E. Bohmer. 1996. Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature. Scand. J. Rheumatol. 25:70-73.
197. 197. Garcia, C., V. Kumar, and O. P. Sharma. 1996. Pancreatic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 13:28-32.
198. 198. Sharma, O., J. Kadakia, and O. Sharma. 1992. Gastronintestinal sarcoidosis. Semin. Respir. Med. 13:442-449.
199. 199. Browne, P. M., O. P. Sharma, and D. Salkin. 1978. Bone marrow sarcoidosis. J.A.M.A. 240:2654-2655.
200. 200. Goldstein, R. A., H. L. Israel, K. L. Becker, and C. F. Moore. 1971. The infrequency of hypercalcemia in sarcoidosis. Am. J. Med. 51:21-30.
201. 201. Sharma, O. P. 1996. Vitamin D, calcium, and sarcoidosis. Chest 109: 535-539.
202. 202. Rizzato, G., and P. Colombo. 1996. Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc. Diffuse Lung Dis. 13:167-172.
203. 203. Papadopoulos, K. I., Y. Hornblad, H. Liljebladh, and B. Hallengren. 1996. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur. J. Endocrinol. 134:331-336.
204. 204. Carmody, J. P., and O. P. Sharma. 1996. Intrascrotal sarcoidosis: case reports and review. Sarcoidosis Vasc. Diffuse Lung Dis. 13:129-134.
205. 205. Sato, A. 1996. Renal dysfunction in patients with sarcoidosis. Intern. Med. 35:523-524.
206. 206. Cruzado, J. M., R. Poveda, J. Mana, L. Carreras, M. Carrera, J. M. Grinyo, and J. Alsina. 1995. Interstitial nephritis in sarcoidosis: simultaneous multiorgan involvement. Am. J. Kidney Dis. 26:947-951.
207. 207. Kendig, E. L., Jr. 1974. The clinical picture of sarcoidosis in children. Pediatrics 54:289-292.
208. 208. James, D. G., and E. L. Kendig, Jr. 1988. Childhood sarcoidosis. Sarcoidosis 5:57-59.
209. 209. Given, F. R., and R. L. DiBendetto. 1963. Sarcoidosis and pregnancy. Obstet. Gynecol. 22:355.
210. 210. Stadnyk, A. N., I. Rubinstein, R. F. Grossman, G. L. Baum, Y. Hiss, A. Solomon, and T. Rosenthal. 1988. Clinical features of sarcoidosis in elderly patients. Sarcoidosis 5:121-123.
211. 211. Conant, E. F., M. F. Glickstein, P. Mahar, and W. T. Miller. 1988. Pulmonary sarcoidosis in the older patient: conventional radiographic features. Radiology 169:315-319.
212. 212. Gilman, M. J., and K. P. Wang. 1980. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am. Rev. Respir. Dis. 122:721-724.
213. 213. Israel, H. L., K. H. Albertine, C. H. Park, and H. Patrick. 1991. Whole-body gallium 67 scans: role in diagosis of sarcoidosis. Am. Rev. Respir. Dis. 144:1182-1186.
214. 67Ga lung scans in assessing sarcoidosis: experience in 14 research centers in seven different countries. Ann. N.Y. Acad. Sci. 465:463-478.
215. 215. Raghu, G. 1995. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am. J. Respir. Crit. Care Med. 151:909-914.
216. 216. Gossot, D., L. Toledo, S. Fritsch, and M. Celerier. 1996. Mediastinoscopy vs thoracoscopy for mediastinal biopsy: results of a prospective nonrandomized study. Chest 110:1328-1331.
217. 217. Hiraga, Y., and Y. Hosoda. 1981. Acceptability of epidemiological diagnostic criteria for sarcoidosis without histological confirmation. In R. Mikami and Y. Hosoda, editors. Sarcoidosis. University of Tokyo Press, Tokyo. 373-377.
218. 218. Costabel, U. 1992. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 9(Suppl. 1):211-214.
219. 219. Winterbauer, R. H., J. Lammert, M. Selland, R. Wu, D. Corley, and S. C. Springmeyer. 1993. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 104:352-361.
220. 220. Bjermer, L., M. Thunell, L. Rosenhall, and N. Stjernberg. 1991. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir. Med. 85:229-324.
221. 221. Stjernberg, N., H. Bjornstad-Pettersen, and H. Truedsson. 1980. Flexible fiberoptic bronchoscopy in sarcoidosis. Acta Med. Scand. 208: 397-399.
222. 222. Armstrong, J. R., J. R. Radke, P. A. Kvale, M. S. Eichenhorn, and J. Popovich, Jr. 1981. Endoscopic findings in sarcoidosis: characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann. Otol. Rhinol. Laryngol. 90:339-343.
223. 223. Sulavik, S. B., R. P. Spencer, D. A. Weed, H. R. Shapiro, S. T. Shiue, and R. J. Castriotta. 1990. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J. Nucl. Med. 31:1909-1914.
224. 224. Siltzbach, L., and J. Ehrlich. 1954. The Nickerson-Kveim reaction in sarcoidosis. Am. J. Med. 16:790-803.
225. 225. James, D. G. 1991. Sarcoidosis today. Sarcoidosis 8:163-165.
226. 226. Allen, R. K. 1991. A review of angiotensin converting enzyme in health and disease. Sarcoidosis 8:95-100.
227. 227. Keogh, B. A., G. W. Hunninghake, B. R. Line, and R. G. Crystal. 1983. The alveolitis of pulmonary sarcoidosis: evaluation of natural history and alveolitis-dependent changes in lung function. Am. Rev. Respir. Dis. 128:256-265.
228. 228. Costabel, U., K. J. Bross, J. Guzman, A. Nilles, K. H. Ruhle, and H. Matthys. 1986. Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann. N.Y. Acad. Sci. 465:418-426.
229. 229. Hunninghake, G. W., S. Gilbert, R. Pueringer, C. Dayton, C. Floerchinger, R. Helmers, R. Merchant, J. Wilson, J. Galvin, and D. Schwartz. 1994. Outcome of the treatment for sarcoidosis [see comments]. Am. J. Respir. Crit. Care Med. 149:893-898.
230. 230. Wells, A. 1998. High resolution computed tomography in sarcoidosis: a clinical perspective [In Process Citation]. Sarcoidosis Vasc. Diffuse Lung Dis. 15:140-146.
231. 231. Costabel, U., R. D. Bois, and A. Eklund. 1994. Consensus conference: activity of sarcoidosis. Sarcoidosis 11:27-33.
232. 232. Semenzato, G. 1993. Assessment of disease activity in sarcoidosis: deeds and misdeeds [Editorial]. Sarcoidosis 10:100-103.
233. 233. Sharma, O. P. 1993. Pulmonary sarcoidosis and corticosteroids. Am. Rev. Respir. Dis. 147:1598-1600.
234. 234. Reich, J. M., and R. E. Johnson. 1985. Course and prognosis of sarcoidosis in a nonreferral setting: analysis of 86 patients observed for 10 years. Am. J. Med. 78:61-67.
235. 235. Takada, K., Y. Ina, M. Noda, T. Sato, M. Yamamoto, and M. Morishita. 1993. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J. Clin. Epidemiol. 46:359-366.
236. 236. Ziegenhagen, M. W., U. K. Benner, G. Zissel, P. Zabel, M. Schlaak, and J. Muller-Quernheim. 1997. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am. J. Respir. Crit. Care Med. 156:1586-1592.
237. 237. Gottlieb, J. E., H. L. Israel, R. M. Steiner, J. Triolo, and H. Patrick. 1997. Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy. Chest 111:623-631.
238. 238. Viskum, K., and J. Vestbo. 1993. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur. Respir. J. 6:349-353.
239. 239. Vestbo, J., and K. Viskum. 1994. Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 11:123-125.
240. 240. Huang, C. T., A. E. Heurich, A. L. Sutton, and H. A. Lyons. 1981. Mortality in sarcoidosis: a changing pattern of the causes of death. Eur. J. Respir. Dis. 62:231-238.
241. 241. Baughman, R. P., D. B. Winget, E. H. Bowen, and E. E. Lower. 1997. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 14:154-158.
242. 242. Israel, H. L., P. Karlin, H. Menduke, and O. G. DeLisser. 1986. Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann. N.Y. Acad. Sci. 465:609-618.
243. 243. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Sarcoidosis. N. Engl. J. Med. 336:1224-1234. [Published erratum appears in N. Engl. J. Med. 1997;337(2):139.]
244. 244. Honeybourne, D. 1980. Ethnic differences in the clinical features of sarcoidosis in south-east London. Br. J. Dis. Chest 74:63-69.
245. 245. Ina, Y., K. Takada, M. Yamamoto, M. Morishita, Y. Senda, and Y. Torii. 1989. HLA and sarcoidosis in the Japanese. Chest 95:1257-1261.
246. 246. Smith, M. J., C. W. Turton, D. N. Mitchell, M. Turner-Warwick, L. M. Morris, and S. D. Lawler. 1981. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 36:296-298.
247. 247. Kunikane, H., S. Abe, Y. Tsuneta, T. Nakayama, Y. Tajima, J. Misonou, A. Wakisaka, M. Aizawa, and Y. Kawakami. 1987. Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am. Rev. Respir. Dis. 135:688-691.
248. 248. Raphael, S. A., E. B. Blau, W. H. Zhang, and S. H. Hsu. 1993. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am. J. Dis. Child 147:842-848.
249. 249. Rizzato, G., and L. Montemurro. 1994. The locomotor system. In D. James, editor. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York. 349-373.
250. 250. Ward, K., C. O'Connor, C. Odlum, and M. X. Fitzgerald. 1989. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 44:6-12.
251. 251. Löfgren, S. 1967. The concept of erythema nodosum revised. Scand. J. Respir. Dis. 48:465-474.
252. 252. Adams, J. 1992. Hypercalcemia and hypercalcuria. Semin. Respir. Med. 13:402-410.
253. 253. Rizzato, G., P. Fraioli, and L. Montemurro. 1995. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 50:555-559.
254. 254. Johnson, D., M. Yamakido, and O. Sharma. 1992. Musculoskeletal involvement in sarcoidosis. Semin. Respir. Med. 13:415-419.
255. 255. Rohatgi, P. 1992. Osseous sarcoidosis. Semin. Respir. Med. 13:468-188.
256. 256. Sartoris, D. J., D. Resnick, C. Resnik, and I. Yaghmai. 1985. Musculoskeletal manifestations of sarcoidosis. Semin. Roentgenol. 20:376-386.
257. 257. Scott, T. F. 1993. Neurosarcoidosis: progress and clinical aspects. Neurology 43:8-12.
258. 258. Aghogu, B. N., B. J. Stern, C. Sewell, and G. Yang. 1995. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch. Neurol. 52:875-879.
259. 259. Baughman, R., E. Lower, and J. Lynch. 1994. Treatment modalities for sarcoidosis. Clin. Pulm. Med. 1:223-231.
260. 260. Lynch, J. P., III, and W. J. McCune. 1997. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am. J. Respir. Crit. Care Med. 155:395-420.
261. 261. Baughman, R. P., R. Shipley, and C. E. Eisentrout. 1987. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung 165:371-377.
262. 262. Hosoda, Y., and R. Mikami. 1986. International controlled clinical trial of prednisone therapy in pulmonary sarcoidosis. Ann. N.Y. Acad. Sci. 465:692-694.
263. 263. Harkleroad, L. E., R. L. Young, P. J. Savage, D. W. Jenkins, and R. E. Lordon. 1982. Pulmonary sarcoidosis: long-term follow-up of the effects of steroid therapy. Chest 82:84-87.
264. 264. Erkkila, S., B. Froseth, P. E. Hellstrom, K. Kaltiokallio, E. Taskinen, A. Viljanen, B. Viljanen, and O. Selroos. 1988. Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. Sarcoidosis 5:106-110.
265. 265. Pictinalho, A., A. Lindholm, T. Haahtcla, P. Tukiainen, and O. Selroos. 1996. Inhaled budesonide for treatment of pulmonary sarcoidosis: results of a double-blind, placebo-controlled, multicentre study. Eur. Respir. J. 9:406s.
266. 266. Selroos, O. 1988. Inhaled corticosteroids and pulmonary sarcoidosis. Sarcoidosis 5:104-105.
267. 267. Spiteri, M. A., S. P. Newman, S. W. Clarke, and L. W. Poulter. 1989. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis, Eur. Respir. J. 2:218-224.
268. 268. Zych, D., L. Pawlicka, and J. Zielinski. 1993. Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis. Sarcoidosis 10:56-61.
269. 269. Milman, N., N. Graudal, G. Grode, and E. Munch. 1994. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J. Intern. Med. 236:285-290.
270. 270. Selroos, O. B. 1986. Use of budesonide in the treatment of pulmonary sarcoidosis. Ann. N.Y. Acad. Sci. 465:713-721.
271. 271. Alberts, C., T. W. van der Mark, and H. M. Jansen. 1995. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur. Respir. J. 8:682-688.
272. 272. Henderson, C. A., A. Ilchyshyn, and A. R. Curry. 1994. Laryngeal and cutaneous sarcoidosis treated with methotrexate. J. R. Soc. Med. 87: 632-633.
273. 273. Israel, H. L. 1970. The treatment of sarcoidosis. Postgrad. Med. J. 46: 537-540.
274. 274. Kaye, O., E. Palazzo, M. Grossin, P. Bourgeois, M. F. Kahn, and M. G. Malaise. 1995. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br. J. Rheumatol. 34:642-644.
275. 275. Lacher, M. J. 1968. Spontaneous remission or response to methotrexate in sarcoidosis. Ann. Intern. Med. 69:1247-1248.
276. 276. Lower, E. E., and R. P. Baughman. 1990. The use of low dose methotrexate in refractory sarcoidosis. Am. J. Med. Sci. 299:153-157.
277. 277. Lower, E. E., and R. P. Baughman. 1995. Prolonged use of methotrexate for sarcoidosis. Arch. Intern. Med. 155:846-851.
278. 278. Rajendran, R., M. Theertham, R. Salgia, and P. Muthuswamy. 1994. Methotrexate in the treatment of cutaneous sarcoidosis. Sarcoidosis 11:S335-S338.
279. 279. Webster, G. F., L. K. Razsi, M. Sanchez, and J. L. Shupack. 1991. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J. Am. Acad. Dermatol. 24:451-454.
280. 280. Gelwan, M. J., R. I. Kellen, R. M. Burde, and M. J. Kupersmith. 1988. Sarcoidosis of the anterior visual pathway: successes and failures. J. Neurol Neurosurg. Psychiatry 51:1473-1480.
281. 281. Sharma, O., D. Hughes, D. James, and P. Naish. 1971. Immunosuppressive therapy with azathioprine in sarcoidosis. In L. Levinsky and F. Macholoa, editors. Fifth International Conference on Sarcoidosis and Other Granulomatous Disorders. Universita Karlova, Prague. 635-637.
282. 282. Hof, D., P. Hof, and W. Godfrey. 1996. Long-term use of azathioprine as a steroid-sparing treatment for chronic sarcoidosis (abstract). Am. J. Respir. Crit. Care Med. 153:A870.
283. 283. Pacheco, Y., C. Marechal, F. Marechal, N. Biot, and M. Perrin Fayolle. 1985. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 2:107-113.
284. 284. Hughes, G. S., Jr., Y. P. Kataria, and T. F. O'Brien, Jr. 1983. Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South. Med. J. 76:1440-1442.
285. 285. Kataria, Y. P. 1980. Chlorambucil in sarcoidosis. Chest 78:36-43.
286. 286. Demeter, S. L. 1988. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest 94:202-203.
287. 287. Kwong, T., E. Valderrama, C. Paley, and N. Ilowite. 1994. Systemic necrotizing vasculitis associated with childhood sarcoidosis. Semin. Arthritis Rheum. 23:388-395.
288. 288. Zuber, M., G. Defer, P. Cesaro, and J. D. Degos. 1992. Efficacy of cyclophosphamide in sarcoid radiculomyelitis [Letter]. J. Neurol. Neurosurg. Psychiatry 55:166-167.
289. 289. Lower, E. E., J. P. Broderick, T. G. Brott, and R. P. Baughman. 1997. Diagnosis and management of neurological sarcoidosis. Arch. Intern. Med [see comments]. 157:1864-1868.
290. 290. Fries, J. F., C. A. Williams, D. Ramey, and D. A. Bloch. 1993. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis. Rheum. 36:297-306.
291. 291. Singh, G., J. F. Fries, C. A. Williams, E. Zatarain, P. Spitz, and D. A. Bloch. 1991. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J. Rheumatol. 18:188-194.
292. 292. Willkens, R. F., M. B. Urowitz, D. M. Stablein, R. J. McKendry, Jr., R. G. Berger, J. H. Box, J. J. Fiechtner, E. J. Fudman, N. P. Hudson, C. R. Marks, et al. 1992. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial [see comments]. Arthritis Rheum. 35:849-856.
293. 293. Anderson, D., J. B. Bishop, R. C. Garner, P. Ostrosky-Wegman, and P. B. Selby. 1995. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res. 330:115-181.
294. 294. Ramsey-Goldman, R., J. M. Mientus, J. E. Kutzer, J. J. Mulvihill, and T. A. Medsger, Jr. 1993. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J. Rheumatol. 20:1152-1157.
295. 295. Bailin, P. L., J. P. Tindall, H. H. Roenigk, Jr., and M. D. Hogan. 1975. Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. J.A.M.A. 232:359-362.
296. 296. Nyfors, A., and H. Jensen. 1983. Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics: a preliminary study. Dermatologica 167:260-261.
297. 297. Rustin, G., F. Rustin, J. Dent, M. Booth, and S. Salt. 1982. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N. Engl. J. Med. 308:473-476.
298. 298. Schnabel, A., C. Richter, S. Bauerfeind, and W. L. Gross. 1997. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 52:377-379.
299. 299. Sostman, H. D., R. A. Matthay, C. E. Putman, and G. J. Smith. 1976. Methotrexate-induced pneumonitis. Medicine 55:371-388.
300. 300. Tolman, K. G., D. O. Clegg, R. G. Lee, and J. R. Ward. 1985. Methotrexate and the liver. J. Rheumatol. 12(Suppl. 12):29-34.
301. 301. Kehinde, E. O., A. Petermann, J. D. Morgan, Z. A. Butt, P. K. Donnelly, P. S. Veitch, and P. R. Bell. 1994. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br. J. Surg. 81:985-986.
302. 302. Ritters, B., B. Grabensee, and P. Hcering. 1994. Malignancy under immunosuppressive therapy including cyclosporine. Transplant Proc. 26: 2656-2657.
303. 303. Taylor, A. E., and S. Shuster. 1992. Skin cancer after renal transplantation: the causal role of azathioprine. Acta Derm. Venereol. 72:115-119.
304. 304. Matteson, E. L., A. R. Hickey, L. Maguire, H. H. Tilson, and M. B. Urowitz. 1991. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry: Rheumatoid Arthritis Azathioprine Registry Steering Committee. J. Rheumatol. 18:809-814.
305. 305. Baker, G. L., L. E. Kahl, B. C. Zee, B. L. Stolzer, A. K. Agarwal, and T. A. Medsger, Jr. 1987. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: long-term case-control follow-up study. Am. J. Med. 83:1-9.
306. 306. Talar-Williams, C., Y. M. Hijazi, M. M. Walther, W. M. Linehan, C. W. Hallahan, I. Lubensky, G. S. Kerr, G. S. Hoffman, A. S. Fauci, and M. C. Sneller. 1996. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis [see comments]. Ann. Intern. Med. 124:477-484.
307. 307. Travis, L. B., R. E. Curtis, B. Glimelius, E. J. Holowaty, F. E. Van Leeuwen, C. F. Lynch, A. Hagenbeek, M. Stovall, P. M. Banks, J. Adami, et al. 1995. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J. Natl. Cancer Inst. 87:524-530.
308. 308. Morgan, S. L., J. E. Baggott, W. H. Vaughn, J. S. Austin, T. A. Veitch, J. Y. Lee, W. J. Koopman, C. L. Krumdieck, and G. S. Alarcon. 1994. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial [see comments]. Ann. Intern. Med. 121:833-841.
309. 309. Ben Ari, Z., A. Mehta, L. Lennard, and A. K. Burroughs. 1995. Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. J. Hepatol. 23:351-354.
310. 310. Escousse, A., C. Mousson, L. Santona, G. Zanetta, J. Mounier, Y. Tanter, F. Duperray, G. Rifle, and D. Chevet. 1995. Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study. Transplant. Proc. 27:1739-1742.
311. 311. Siltzbach, L. E., and A. S. Teirstein. 1964. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med. Scand. Suppl. 425:302-308.
312. 312. Adams, J. S., M. M. Diz, and O. P. Sharma. 1989. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann. Intern. Med. 111:437-438.
313. 313. Association, B. T. 1967. Chloroquine in the treatment of sarcoidosis. Tubercle 47:252-257.
314. 314. Zic, J. A., D. H. Horowitz, C. Arzubiaga, and L. E. King, Jr. 1991. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch. Dermatol. 127:1034-1040.
315. 315. Quatraro, A., G. Consoli, M. Magno, F. Caretta, A. Nardozza, A. Ceriello, and D. Giugliano. 1990. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus: a new job for an old drug? Ann. Intern. Med. 112:678-681.
316. 316. Adams, J. S., O. P. Sharma, M. M. Diz, and D. B. Endres. 1990. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J. Clin. Endocrinol. Metab. 70:1090-1095.
317. 317. Ejaz, A. A., R. I. Zabaneh, P. Tiwari, Z. M. Nawab, D. J. Leehey, and T. S. Ing. 1994. Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis. Nephrol. Dial. Transplant. 9:1492-1494.
318. 318. Pia, G., L. Pascalis, G. Aresu, L. Rosetti, and M. A. Ledda. 1996. Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 13:146-152.
319. 319. Martinet, Y., P. Pinkston, C. Saltini, J. Spurzem, J. Muller-Quernheim, and R. G. Crystal. 1988. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 138:1242-1248.
320. 320. Wyser, C. P., E. M. van Schalkwyk, B. Alheit, P. G. Bardin, and J. R. Joubert. 1997. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 1556:1371-1376.
321. 321. Stern, B. J., S. A. Schonfeld, C. Sewell, A. Krumholz, P. Scott, and G. Belendiuk. 1992. The treatment of neurosarcoidosis with cyclosporine. Arch. Neurol. 49:1065-1072.
322. 322. Ahmad, K., Y. H. Kim, A. R. Spitzer, A. Gupta, I. H. Han, A. Herskovic, and W. A. Sakr. 1992. Total nodal radiation in progressive sarcoidosis: case report. Am. J. Clin. Oncol. 15:311-313.
323. 323. Cagnoni, M. L., A. Lombardi, M. C. Cerinic, G. L. Dedola, and A. Pignone. 1995. Melatonin for treatment of chronic refractory sarcoidosis [Letter]. I.ancet 346:1229-1230.
324. 324. Carlesimo, M., S. Giustini, A. Rossi, P. Bonaccorsi, and S. Calvieri. 1995. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J. Am. Acad. Dermatol. 32:866-869.
325. 325. Zabel, P., P. Entzian, K. Dalhoff, and M. Schlaak. 1997. Pentoxifylline in treatment of sarcoidosis. Am. J. Respir. Crit. Care Med. 155:1665-1669.
326. 326. Rizzato, G., and L. Montemurro. 1993. Reversibility of exogenous corticosteroid-induced bone loss. Eur. Respir. J. 6:116-119.
327. 327. Rizzato, G., P. Fraioli, and L. Montemurro. 1991. Long-term therapy with deflazacort in chronic sarcoidosis. Chest 99:301-309.
328. 328. Montemurro, L., G. Schiraldi, P. Fraioli, G. Tosi, A. Riboldi, and G. Rizzato. 1991. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif. Tissue Int. 49:71-76.
329. 329. Padilla, M. L., G. J. Schilero, and A. S. Teirstein. 1997. Sarcoidosis and transplantation. Sarcoidosis Vasc. Diffuse Lung Dis. 14:16-22.
330. 330. Martinez, F. J., J. B. Orens, M. Deeb, L. A. Brunsting, A. Flint, and J. P. Lynch, 3rd. 1994. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 106:1597-1599.
331. 331. Casavilla, F. A., R. Gordon, H. I. Wright, J. S. Gavaler, T. E. Starzl, and D. H. Van Thiel. 1993. Clinical course after liver transplantation in patients with sarcoidosis. Ann. Intern. Med. 118:865-866.